MedPath

Behavioral Neurocardiac Training and Hypertension

Not Applicable
Completed
Conditions
Hypertension
Interventions
Behavioral: Behavioral neurocardiac training
Behavioral: Autogenic relaxation training
Registration Number
NCT00811811
Lead Sponsor
University Health Network, Toronto
Brief Summary

This randomized controlled trial will examine whether behavioral neurocardiac training with heart rate variability biofeedback (BNT) augments reduction in ambulatory daytime and 24-hour SBP, DBP and PP, in comparison to an active control intervention (AC, autogenic relaxation training), among subjects diagnosed with hypertension, and following adjustment for medications. In addition, the independent association between the BNT and AC interventions on vagal-heart rate modulation and baroreflex sensitivity will be evaluated during a standardized assessment protocol of mental stress testing. This study extends a previous trial conducted at the UHN, in which we reported that the biofeedback intervention independently augments vagal-heart rate modulation, while reducing symptoms of stress and depressed mood, among subjects diagnosed with cardiovascular disease. Exploratory features of this trial will examine the association between ambulatory blood pressure, vagal-heart rate modulation, baroreflex sensitivity, and markers of inflammatory activity.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
65
Inclusion Criteria

Not provided

Read More
Exclusion Criteria

Not provided

Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
1Behavioral neurocardiac trainingBehavioral neurocardiac training
2Autogenic relaxation trainingAutogenic relaxation training
Primary Outcome Measures
NameTimeMethod
Ambulatory daytime and 24-hour systolic blood pressure, diastolic blood pressure, and pulse pressure.Baseline and Post-treatment (following 6 treatment sessions scheduled over an 8-week interval)
Secondary Outcome Measures
NameTimeMethod
RR interval, vagal-heart rate modulation (high frequency power in RR interval variability [0.15-0.40 Hz/ms2]) and baroreflex sensitivity8 weeks

Trial Locations

Locations (1)

Toronto General Hospital

🇨🇦

Toronto, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath